← Leaderboards
Namita Roy-Chowdhury
Yeshiva University
$4,062,736
Attributed
$4,062,736
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $450.8K · FY2005–16$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$4,062,736 · 5
By mechanism
R01$4,059,315 · 3
M01$3,421 · 2
Top collaborators
No co-investigators on record.
Most similar at Yeshiva University
Same institution · by research overlap
- Jayanta Roy-Chowdhury$7,989,633
- David A Shafritz$12,613,259
- Liang Zhu$8,288,823
Others in their field
Top investigators on “Glucuronosyltransferase”
- Robert H Tukey · University Of California San Diego$11,818,423
- Philip Lazarus · Washington State University$10,398,019
- M. Peter Lance · University Of Arizona$9,350,950
- Stephen Marc Schwartz · Fred Hutchinson Cancer Research Center$6,502,051
- Ming Hu · Washington State University$5,453,576
- Lang Li · Indiana Univ-Purdue Univ At Indianapolis$4,522,266
Research focus
GlucuronosyltransferaseBaseGene ExpressionGenesIrradiationMitoticMutationHepaticLiver TransplantationHepatocyteInheritedBilirubinLaboratoriesMinimally InvasiveAdenovirus VectorLifeAutologousLiverGraft RejectionCellsMetabolic DiseasesCell TransplantsExcretory FunctionNatural Immunosuppression
Grant awards (14)
Deriving hepatocytes from disease specific iPS to treat metabolic liver disorders$392,425
R01 · FY2016 · DK · contact PI
Deriving hepatocytes from disease specific iPS to treat metabolic liver disorders$56,371
R01 · FY2016 · DK · contact PI
Deriving hepatocytes from disease specific iPS to treat metabolic liver disorders$449,833
R01 · FY2015 · DK · contact PI
Deriving hepatocytes from disease specific iPS to treat metabolic liver disorders$450,838
R01 · FY2014 · DK · contact PI
Deriving hepatocytes from disease specific iPS to treat metabolic liver disorders$442,233
R01 · FY2013 · DK · contact PI
Hepatocyte - Based Therapies of Primary Hyperoxaluria 1$331,998
R01 · FY2010 · DK · contact PI
Hepatocyte - Based Therapies of Primary Hyperoxaluria 1$324,342
R01 · FY2009 · DK · contact PI
BILIRUBIN$511
M01 · FY2008 · RR · contact PI
INHERITED DISORDERS OF HEPATIC BILIRUBIN GLUCORONIDATION$315,961
R01 · FY2006 · DK · contact PI
INHERITED DISORDERS OF HEPATIC BILIRUBIN GLUCORONIDATION$323,564
R01 · FY2005 · DK
INHERITED DISORDERS OF HEPATIC BILIRUBIN GLUCORONIDATION$323,564
R01 · FY2004 · DK
BILIRUBIN$2,910
M01 · FY2004 · RR
INHERITED DISORDERS OF HEPATIC BILIRUBIN GLUCORONIDATION$365,313
R01 · FY2003 · DK
INHERITED DISORDERS OF HEPATIC BILIRUBIN GLUCURONIDATION$282,873
R01 · FY2000 · DK